The optimal treatment of non-infarct-related coronary arteries in patients presenting with ST-elevation myocardial infarction (STEMI) has been a subject of debate for many years. Earlier medium-sized randomized controlled trials reported a benefit of multivessel percutaneous coronary intervention (PCI) primarily due to a reduction of subsequent revascularizations. Recently, the well-powered COMPLETE trial showed a reduction in the composite endpoint of cardiovascular mortality and myocardial reinfarction through complete revascularization. The present review summarizes the current evidence regarding revascularization strategies in STEMI patients.

中文翻译：

---

仅在ST段抬高型心肌梗死中经皮冠状动脉介入治疗多支血管病变。

患有ST抬高型心肌梗死（STEMI）的患者中非梗塞相关冠状动脉的最佳治疗方法一直是争论的话题。较早的中型随机对照试验报道了多支血管经皮冠状动脉介入治疗（PCI）的益处，主要是因为减少了随后的血运重建。最近，功能强大的COMPLETE试验表明，通过完全血运重建可以降低心血管疾病死亡率和心肌梗死的综合终点。本综述总结了有关STEMI患者血运重建策略的最新证据。